Health and Healthcare

Biogen : BIIB

All Biogen Articles

607 Articles

Jon C. Ogg | Sep 13, 2017 at 7:15 AM EDT

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown…

Chris Lange | Aug 25, 2017 at 10:10 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The August 15 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Aug 10, 2017 at 8:50 AM EDT

Major Biotechs Send Short Sellers Running for Cover

The July 31 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Aug 2, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Caterpillar, Pfizer, Royal Caribbean, Shopify, Under Armour, Walmart and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Apple, Caterpillar, Pfizer, Royal Caribbean, Shopify, Under Armour…

Lee Jackson | Jul 28, 2017 at 10:20 AM EDT

Analyst Has Top Biotech Stocks to Buy as Sector Stays Red Hot

After a wretched 2016, when many of the top biotech companies were hit hard by campaign rhetoric, the industry has…

Chris Lange | Jul 26, 2017 at 9:35 AM EDT

Short Sellers Run for Cover From Major Biotech Stocks

The July 14 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jul 13, 2017 at 9:40 AM EDT

Short Sellers Hike Bets in Major Biotechs

The June 30 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jul 11, 2017 at 12:10 PM EDT

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's…

Chris Lange | Jun 27, 2017 at 8:50 AM EDT

Major Biotech Short Interest Surges

The June 15 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Jun 23, 2017 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and Many More

The top analyst upgrades, downgrades and other research calls from Friday include AK Steel, Altice USA, Biogen, Caterpillar, Gilead Sciences…

Jon C. Ogg | Jun 20, 2017 at 10:45 AM EDT

Large Insider Buying at Alexion Raises Investors’ Eyebrows

Most of the large biotech outfits in America have gone into a limbo mode. Alexion Pharmaceuticals fits that bill despite…

Jon C. Ogg | Jun 19, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Amazon, Biogen, Costco, Kroger, Travelers, Wayfair and Many More

The top analyst upgrades, downgrades and other research calls from Monday include Amazon.com, Biogen, Costco Wholesale, Kroger, Travelers and Wayfair.

Chris Lange | Jun 14, 2017 at 9:15 AM EDT

Alexion Pharmaceuticals Adds New CFO From Biogen

Shares of Alexion Pharmaceuticals saw a handy gain early on Wednesday after the company announced that there would be changes…

Chris Lange | Jun 12, 2017 at 9:40 AM EDT

Short Interest Surges in Major Biotechs

The May 31 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | May 25, 2017 at 9:50 AM EDT

Short Sellers Raise the Stakes in Major Biotechs

The May 15 short interest data have been compared with the previous report, and moves in the selected biotech stocks…

1 … 15 16 17 18 19 … 41

Biogen : BIIB

All Biogen Articles

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Major Biotechs Send Short Sellers Running for Cover

Top Analyst Upgrades and Downgrades: Apple, Caterpillar, Pfizer, Royal Caribbean, Shopify, Under Armour, Walmart and More

Analyst Has Top Biotech Stocks to Buy as Sector Stays Red Hot

Short Sellers Run for Cover From Major Biotech Stocks

Short Sellers Hike Bets in Major Biotechs

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

Major Biotech Short Interest Surges

Top Analyst Upgrades and Downgrades: AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and Many More

Large Insider Buying at Alexion Raises Investors’ Eyebrows

Top Analyst Upgrades and Downgrades: Amazon, Biogen, Costco, Kroger, Travelers, Wayfair and Many More

Alexion Pharmaceuticals Adds New CFO From Biogen

Short Interest Surges in Major Biotechs

Short Sellers Raise the Stakes in Major Biotechs

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

Biogen : BIIB

All Biogen Articles

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Major Biotechs Send Short Sellers Running for Cover

Top Analyst Upgrades and Downgrades: Apple, Caterpillar, Pfizer, Royal Caribbean, Shopify, Under Armour, Walmart and More

Analyst Has Top Biotech Stocks to Buy as Sector Stays Red Hot

Short Sellers Run for Cover From Major Biotech Stocks

Short Sellers Hike Bets in Major Biotechs

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

Major Biotech Short Interest Surges

Top Analyst Upgrades and Downgrades: AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and Many More

Large Insider Buying at Alexion Raises Investors’ Eyebrows

Top Analyst Upgrades and Downgrades: Amazon, Biogen, Costco, Kroger, Travelers, Wayfair and Many More

Alexion Pharmaceuticals Adds New CFO From Biogen

Short Interest Surges in Major Biotechs

Short Sellers Raise the Stakes in Major Biotechs

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

Featured Reads

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line